| Title: | Large-scale analysis to identify risk factors for ovarian cancer |
| Journal: | International Journal of Gynecological Cancer |
| Published: | 6 Jan 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39084694/ |
| DOI: | https://doi.org/10.1136/ijgc-2024-005424 |
| URL: | https://ijgc.bmj.com/content/ijgc/early/2024/07/30/ijgc-2024-005424.full.pdf |
Publication 12755
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
OBJECTIVE: Ovarian cancer is characterized by late-stage diagnoses and poor prognosis. We aimed to identify factors that can inform prevention and early detection of ovarian cancer.</p>
METHODS: We used a data-driven machine learning approach to identify predictors of epithelial ovarian cancer from 2920 input features measured 12.6 years (IQR 11.9 to 13.3 years) before diagnoses. Analyses included 221 732 female participants in the UK Biobank without a history of cancer. During the follow-up 1441 women developed ovarian cancer. For factors that contributed to model prediction, we used multivariate logistic regression to evaluate the association with ovarian cancer, with evidence for causality tested by Mendelian randomization (MR) analyses in the Ovarian Cancer Genetics Consortium (25 509 cases).</p>
RESULTS: Greater parity and ever-use of oral contraception were associated with lower ovarian cancer risk (ever vs never OR 0.74, 95% CI 0.66 to 0.84). After adjustment for established risk factors, greater height, weight, and greater red blood cell distribution width were associated with increased ovarian cancer risk, while higher aspartate aminotransferase levels and mean corpuscular volume were associated with lower risk. MR analyses confirmed observational associations with anthropometric/adiposity traits (eg, body fat percentage per standard deviation (SD); OR inverse-variance weighted (ORIVW) 1.28, 95% CI 1.13 to 1.46) and aspartate aminotransferase (ORIVW 0.87, 95% CI 0.78 to 0.98). MR also provided genetic evidence for a protective association of higher total serum protein on ovarian cancer, higher lymphocyte count on serous and endometrioid ovarian cancer, and greater forced expiratory volume in 1 s on serous ovarian cancer among other findings.</p>
CONCLUSIONS: This study shows that certain risk factors for ovarian cancer are modifiable, suggesting that weight reduction and interventions to reduce the number of ovulations may provide potential for future prevention. We also identified blood biomarkers associated with ovarian cancer years before diagnoses, warranting further investigation.</p>
6 Authors
- Iqbal Madakkatel
- Amanda L Lumsden
- Anwar Mulugeta
- Johanna Mäenpää
- Martin K Oehler
- Elina Hyppönen
1 Application
| Application ID | Title |
|---|---|
| 89630 | Improving disease risk prediction and prevention |
Enabling scientific discoveries that improve human health